首页 › 股票 › BCTXL

BCTXL — BRIACELL THERAPEUTICS CORP

申报持仓市值$2.93M
持有基金数(最新)16
板块医疗保健

什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么

持有机构数 (Q2 2026)10
机构持仓市值$2.53M · 2.96M 股
新建/增持/减仓/清仓0 / 1 / 4 / 5 · 更新于 2026-11-14
前五大/前十大集中度75.9% / 100.0%
机构整体持仓变动 减持 -12.3% (-416.24K 股)
机构持仓市值变动 下降 -26.2%

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

截至Q2 2026,共 10 家机构在其最新 13F 申报中持有 BCTXL(BRIACELL THERAPEUTICS CORP),合计申报市值 $2.53M,对应 2.96M 股。按股数计算较上季度减持 12.3%(-416.24K 股),申报市值环比下降 26.2%。持仓集中度较高:前五大持有人占申报市值的 75.9%,前十大的集中度为 100.0%。

与上一季度相比,1 家加仓、4 家减仓、5 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。

BRIACELL THERAPEUTICS CORP(BCTXL)的主要机构持有人包括 Citadel Advisors、ARMISTICE CAPITAL, LLC、Cable Car Capital, LP,按 13F 申报市值在本页 16 家持有人中排名居前。

BCTXL 属于Health Care板块。

本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。

机构逐季持仓趋势

季度 持有机构数 股数 金额 环比净变动
Q3 2026 5 579.64K $672.39K -5.4%
Q2 2026 10 2.96M $2.53M -12.3%
Q1 2026 15 3.57M $3.70M —

表内 3 个季度中,机构持股合计减少 84%(Q1 2026 → Q3 2026);单季变动最大的是 Q2 2026(-12.3%)。

前 25 大机构持仓人(Q3 2026) — 5 家基金

基金股数金额组合权重变化
MYDA Advisors LLC 195.00K $226.20K 0.03% 持有
Warberg Asset Management LLC 181.61K $210.67K 0.05% 增持
SABBY MANAGEMENT, LLC 历史持仓 136.37K $158.18K 3.52% 减持
IRIDIAN ASSET MANAGEMENT LLC/CT 历史持仓 65.00K $75.40K 0.03% 持有
UBS Group AG 1.67K $1.94K 0.00% 新进

↑ 返回持仓列表顶部

更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人

Q2 2026 — 10 家基金

基金股数金额组合权重变化
Citadel Advisors 895.86K $716.78K 0.00% 减持
ARMISTICE CAPITAL, LLC 536.60K $477.57K 0.01% 持有
Cable Car Capital, LP 321.90K $286.49K 0.01% 持有
Empery Asset Management, LP 历史持仓 300.00K $267.00K 0.31% 持有
MYDA Advisors LLC 195.82K $174.28K 0.04% 减持
SABBY MANAGEMENT, LLC 历史持仓 190.38K $169.44K 1.23% 减持
HEIGHTS CAPITAL MANAGEMENT, INC 186.58K $149.28K 0.03% 减持
Warberg Asset Management LLC 159.56K $142.00K 0.05% 增持
Clear Street Group Inc. 104.20K $92.73K 0.00% 持有
IRIDIAN ASSET MANAGEMENT LLC/CT 历史持仓 65.00K $57.85K 0.02% 持有

Q1 2026 — 15 家基金

基金股数金额组合权重变化
Citadel Advisors 1.05M $1.05M 0.00% 新进
ARMISTICE CAPITAL, LLC 536.60K $552.75K 0.01% 新进
SABBY MANAGEMENT, LLC 历史持仓 380.69K $392.14K 4.58% 新进
Cable Car Capital, LP 321.90K $331.59K 0.12% 新进
Empery Asset Management, LP 历史持仓 300.00K $309.03K 0.37% 新进
HEIGHTS CAPITAL MANAGEMENT, INC 300.00K $300.00K 0.08% 新进
MYDA Advisors LLC 200.00K $206.02K 0.05% 新进
Hudson Bay Capital Management LP 125.40K $125.40K 0.00% 新进
Warberg Asset Management LLC 115.00K $118.46K 0.06% 新进
Clear Street Group Inc. 104.20K $107.33K 0.00% 新进
BOOTHBAY FUND MANAGEMENT, LLC 20.00K $83.80K 0.00% 新进
IRIDIAN ASSET MANAGEMENT LLC/CT 历史持仓 65.00K $66.96K 0.03% 新进
LuminArx Capital Management LP 25.00K $25.75K 0.02% 新进
SUSQUEHANNA INTERNATIONAL GROUP, LLP 23.89K $23.89K 0.00% 新进
FNY Investment Advisers, LLC 7.50K $7.00K 0.00% 新进

新建仓(Q2 2026)

本季度没有基金新建该仓位。

完全清仓(较上季)

基金持仓历史 — 各季度股数(前 16 只基金)

基金Q3 2026Q2 2026Q1 2026
MYDA Advisors LLC 195.00K 195.82K 200.00K
Warberg Asset Management LLC 181.61K 159.56K 115.00K
SABBY MANAGEMENT, LLC 136.37K 190.38K 380.69K
IRIDIAN ASSET MANAGEMENT LLC/CT 65.00K 65.00K 65.00K
UBS Group AG 1.67K — —
Citadel Advisors — 895.86K 1.05M
ARMISTICE CAPITAL, LLC — 536.60K 536.60K
Cable Car Capital, LP — 321.90K 321.90K
Empery Asset Management, LP — 300.00K 300.00K
HEIGHTS CAPITAL MANAGEMENT, INC — 186.58K 300.00K
Hudson Bay Capital Management LP — — 125.40K
Clear Street Group Inc. — 104.20K 104.20K
BOOTHBAY FUND MANAGEMENT, LLC — — 20.00K
LuminArx Capital Management LP — — 25.00K
SUSQUEHANNA INTERNATIONAL GROUP, LLP — — 23.89K
FNY Investment Advisers, LLC — — 7.50K

下载持有人名单 (CSV)

常见问题

Which funds hold BCTXL?

As of 2026-Q2, 10 institutional funds reported holding BCTXL (BRIACELL THERAPEUTICS CORP) in SEC 13F filings, with a combined reported value of $2.53M.

How many shares of BCTXL do institutions own?

13F filers reported 2.96M shares of BCTXL, worth $2.53M in aggregate at the end of 2026-Q2.

Is institutional ownership of BCTXL rising or falling?

Share counts moved -12.3% versus the prior quarter — distribution.

Who are the top institutional holders of BCTXL?

The largest 13F holders are Citadel Advisors, ARMISTICE CAPITAL, LLC, Cable Car Capital, LP, Empery Asset Management, LP, MYDA Advisors LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of BRIACELL THERAPEUTICS CORP?

The major shareholders of BRIACELL THERAPEUTICS CORP (BCTXL) by reported 13F value are Citadel Advisors, ARMISTICE CAPITAL, LLC, Cable Car Capital, LP, Empery Asset Management, LP, MYDA Advisors LLC, among 16 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

将本股票嵌入你的网站

复制下面的代码,即可在你的博客或论坛上展示「哪些传奇投资人持有 BCTXL」的实时名单——免费、自动更新、回链 HoldingsHub。

<iframe src="https://holdingshub.top/stocks/BCTXL/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

预览可嵌入组件 →